I-DHA (docosahexaenoic acid) i-omega-3 fatty acid iyanconywa kubafazi ngexesha lokukhulelwa. Ukucinga ukukhusela kwinani leengxaki ezinxulumene nokukhulelwa, i-DHA iphinda kuthiwa iphromotha impilo yemntwana okhulayo.
Efunyanwe kwiintlanzi ezinamafutha abanda abandayo kunye nolwandle, iDHA nayo iyafumaneka ngokubanzi kwifom yokongeza. Ukongezelela, umzimba uvelisa ngokwemvelo isixa esincinci se-DHA.
Ukusetyenziswa kwe-DHA ekukhulelweni
I-DHA icingelwa ukukhusela iingxaki ezithile zezempilo ezichaphazelekayo ngokukhulelwa, njenge- preeclampsia . Ukongezelela, i-DHA idla ngohlobo lwezinto zendalo zokuthintela ukukhulelwa kwesisu nokuhanjiswa kwangethuba. Abanye besetyhini nabo bathatha i-DHA ngexesha lokukhulelwa ukunciphisa ingozi yokuxinezeleka kwangemva kokuphuma.
Ekubeni i-DHA ibalulekile ekuphuculeni i-neurological and visual, abafazi basoloko bathatha i-DHA ngexesha lokukhulelwa ukuqinisekisa ukuba umntwana okhulayo ufumana inani elaneleyo le-DHA.
Izinzuzo ze-DHA Ngethuba lokukhulelwa
Nanku ukukhangela kwiziphumo eziphambili kwiziphumo malunga nokusetyenziswa kwe-DHA ngexesha lokukhulelwa:
1) Ukuphuhlisa abantwana
Kuze kube ngoku, izifundo malunga nokusetyenziswa komama ka-DHA kunye neenzuzo zayo kumntwana okhulayo zivelise iziphumo ezidibeneyo. Ngokomzekelo, kwisifundo se-2011 esashicilelwe kwi- Pediatrics , abaphandi bafumanisa ukuba ukuchitha i-DHA ngexesha lokukhulelwa kuncede ukukhusela iintsana ekuguleni kwasekusaneni. Uhlolisiso lwabandakanya abafazi abakhulelweyo abayi-1,100 kunye neentsana ezingama-900.
Iziphumo zityhila ukuba abantwana basetyhini abathatha u-400 mg we-DHA ngosuku ngalunye lwabo lwabo lokukhulelwa babengenabunzima bokubonakalisa iimpawu ezibandayo kwiinyanga ezimbalwa zokuqala zobomi (xa kuthelekiswa nabantwana abazalelwe oomama banikwe indawo ye-placebo ngexesha lokukhulelwa).
Nangona kunjalo, kolunye uhlolisiso kunyaka ofanayo (lo xesha kwi- American Journal of Clinical Nutrition ), abaphandi bafumanisa ukuba ukusetyenziswa komama ka-DHA isongezelelo akuzange kuphazamise ukuveliswa kwangaphambili kwintsana.
Uhlolisiso lwabandakanya amabhinqa angama-182, elowo lafumana i-800 mg ye-DHA okanye isongezelelo se-placebo ukususela phakathi kwexesha lokukhulelwa ukunikezelwa. Kwiimvavanyo zenziwa xa iintsana zabafundi bezinyanga ezine ubudala, abo oomama babo bathatha i-DHA yongezelelo abazange babonakale banokubonakala kwamehlo.
2) Uxinzelelo lwePostpartum
I-DHA ingenakunceda ukunqanda ukuxinezeleka kwe-postpartum, ngo-2010 uphando olupapashwe kwi- Journal ye-American Medical Association . Kwisifundo, abafazi abangama-2,399 bathatha i-800 mg ye-DHA okanye indawo ye-placebo yonke imihla ukususela kwiiveki ezingama-21 (okanye ngaphantsi) zokukhulelwa de kube sekubelekeni. Ekhangela ulwazi oluqokelelwe kwiinyanga ezintandathu emva kokubeleka, abaphandi bafumanisa ukuba iimpawu zokudakumba kokugqithiswa kwe-postpartum azifani phakathi kwamaqela amabini okufunda.
Ngaphezu koko, amanqaku aphakathi kwengqondo kubantwana besifazane kwiqela le-DHA awazange ahluke kumanqaku aphakathi kwabantwana besetyhini kwiqela le-placebo. Ezinye iziphumo zophuhliso (ezifana nokuphuhlisa imoto kunye nokuziphatha komoya-ntliziyo) nazo zahluleka ukuhluka phakathi kwamaqela amabini.
3) Preeclampsia
Uphando malunga nokusetyenziswa kwe-DHA ekukhuselweni kwe-preeclampsia kuncinci. Nangona kunjalo, ngo-2011 abafundi abangama-109 abakhulelweyo (eshicilelwe kwiProstaglandins, Leukotrienes, kunye ne-Essential Fatty Acids ), abaphandi bafumanisa ukuba amanqanaba e-DHA aphantsi kwalabo abane-preeclampsia (xa kuthelekiswa nalabo banegazi eliqhelekileyo).
Ngokwababhali bokufunda, oku kufumaniswa kukubonisa ukuba iDHA inokukunceda ukukhusela kwi-preeclampsia.
Imijelo
Ngokutsho kweZiko leSizwe lezeMpilo (NIH), ukusetyenziswa kwe-DHA ngokwefuthe leoli yeentlanzi kunokukhuseleka ngexesha lokukhulelwa. I-NIH icebisa ukunciphisa ioli yeentlanzi kwi-3 grams ngosuku xa ukhulelwe.
Kubalulekile ukuba uqaphele ukuba ukuthatha i-DHA ngendlela yeoli yeentlanzi kuyaziwa ukuba kubangele imiphumo emibi, kuquka ukuphefumula kakubi, ukuguquka kwentliziyo, kunye nesiphithiphithi.
Kubalulekile ukugcina engqondweni ukuba izongezelelo azange zivivinywe ukukhusela kunye nezondlo zokutya zikhululekile.
Kwezinye iimeko, loo mveliso inokuhambisa amaxabiso ahluke kwixabiso elichaziweyo kwiyeza ngalinye. Kwezinye iimeko, loo mveliso inokungcoliswa nezinye izinto ezifana nezitye. Kananjalo, ngokubanzi, ukhuseleko lwezongezelelo kubasetyhini abakhulelweyo, oomama abangabongikazi, abantwana, kunye nalabo abanezifo zonyango okanye abo bathabatha imishanguzo ayilwanga.
Kuphi ukuwufumana
Ukufumaneka ngokubanzi ekuthengeni i-intanethi, izongezelelo ze-DHA zithengiswa kwiindawo ezininzi zokuthengisa izidlo, izitolo zokutya, izitolo zokutya zendalo, kunye nezitolo ezizodwa ezizongeziweyo zokutya.
Ukusebenzisa i-DHA ngexesha lokukhulelwa
Ekubeni i-DHA inokunikela ngezibonelelo ezithile kumama olindelekileyo kunye nomntwana wakhe okhulayo, kunokunceda ukuthatha i-DHA ngexesha lokukhulelwa. Nangona kunjalo, ukuba ucinga ngokuthatha isongezelelo se-DHA, kubalulekile ukuba udibane nodokotela wakho kuqala.
Imithombo:
Imhoff-Kunsch B, Stein AD, Martorell R, Parra-Cabrera S, uRomieu I, uRamakrishnan U. "Ukuxhaswa kwe-Acrenatal Docoshexaenoic Acid kunye ne-Infant Morbidity: I-Trimmed Control Trial." Pediatrics. 2011 uAgasti 1.
Kulkarni AV, Mehendale SS, Yadav HR, Joshi SR. "Amazinga e-placental docosahexaenoic eyancitshisiwe anxulumene namazinga akhulayo we-sFlt-1 kwi-preeclampsia." Iprostaglandins iLeukot Essent Fatty Acids. Ngo-2011 uJan-Feb; 84 (1-2): 51-5.
Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P; DOMInO Iqela loPhando. "Impembelelo yokuxhaswa kwe-DHA ngexesha lokukhulelwa kwixinzelelo lokubeleka kunye nokuphuhliswa kwabantwana abancinci. JAMA. 2010 u-Oktobha 20; 304 (15): 1675-83.
AmaZiko eZiko lezeMpilo. Ioli yeentlanzi: i-MedlinePlus Supplements. Ja nuwari 2011.
Smithers LG, iGibson RA, Makrides M. "Ukuxhaswa komama kunye ne-docosahexaenoic acid ngexesha lokukhulelwa akuchaphazeli ukuphuhliswa kokuqala kwintsana: ityala elilawulwa ngokungahleliwe." Am J Clin Nutrition. 2011 Juni; 93 (6): 1293-9.